KIAA1967 Antibody (monoclonal) (M04)
Mouse monoclonal antibody raised against a full length recombinant KIAA1967.
|Application ||WB, IF|
|Calculated MW||102902 Da|
|Other Names||Cell cycle and apoptosis regulator protein 2, Cell division cycle and apoptosis regulator protein 2, DBIRD complex subunit KIAA1967, Deleted in breast cancer gene 1 protein, DBC-1, DBC1, p30 DBC, CCAR2, DBC1, KIAA1967|
|Target/Specificity||KIAA1967 (AAH18269, 5 a.a. ~ 365 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||KIAA1967 Antibody (monoclonal) (M04) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Identification of DBC1 as a transcriptional repressor for BRCA1. Hiraike H, et al. Br J Cancer, 2010 Mar 16. PMID 20160719.Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. Escande C, et al. J Clin Invest, 2010 Feb 1. PMID 20071779.p30 DBC is a potential regulator of tumorigenesis. Kim JE, et al. Cell Cycle, 2009 Sep 15. PMID 19657230.Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Cha EJ, et al. Clin Cancer Res, 2009 Jul 1. PMID 19509139.Inhibition of SUV39H1 methyltransferase activity by DBC1. Li Z, et al. J Biol Chem, 2009 Apr 17. PMID 19218236.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.